ELI LILLY & Co — Director's Dealing 2023

Mar 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ELI LILLY & Co (LLY)
CIK: 0000059478
Period of Report: 2023-03-01

Reporting Person: Zakrowski Donald A (SVP, Finance, & CAO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-03-01	Restricted Stock Unit	$	A	1274	Acquired	2027-03-01	Common Stock (1274.0)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	6578	Direct
Common Stock	1702	Indirect

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.